Cosmo Bio Co (TSE:3386) Total Stockholders Equity: 円9,758 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:3386 Cosmo Bio Co Ltd TSE:3386
72 GF Score
Price 円1,246.00
GF Value 円1,314.21
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Cosmo Bio Co Total Stockholders Equity?

Cosmo Bio Co TSE:3386 +0.48% 72 Total Stockholders Equity is 円9,758 Mil as of Jun. 2026. GuruFocus rates TSE:3386 with a GF Score™ of 72/100 and a GF Value™ of 円1,314.21 (Fairly Valued). The stock has 4 warning signs investors should review.

Cosmo Bio Co's Total Stockholders Equity for the quarter that ended in Jun. 2026 was 円9,758 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Cosmo Bio Co's Book Value per Share for the quarter that ended in Jun. 2026 was 円1,712.55. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Cosmo Bio Co's Debt-to-Equity for the quarter that ended in Jun. 2026 was 0.08.

Cosmo Bio Co  (TSE:3386) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Cosmo Bio Co's Book Value per Share for the quarter that ended in Jun. 2026 is

Book Value per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(9758-0)/5.697921
=1,712.55

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Cosmo Bio Co's Debt-to-Equity for the quarter that ended in Jun. 2026 is

Debt-to-Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(20 + 717) / 9758
=0.08

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cosmo Bio Co Total Stockholders Equity Related Terms

Cosmo Bio Co Total Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Cosmo Bio Co's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cosmo Bio Co Total Stockholders Equity Chart

Cosmo Bio Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7,787.00 8,052.00 8,445.00 8,968.00 9,373.00

Cosmo Bio Co Quarterly Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9,197.00 8,968.00 9,084.00 9,373.00 9,758.00
TSE:3386
72GF Score
Cosmo Bio Co Ltd TSE:3386
Total Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Total Stockholders Equity of 円9,758 Mil mean?
Cosmo Bio Co (TSE:3386) has a Total Stockholders Equity of 円9,758 Mil as of Jun. 2026. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Cosmo Bio Co and its competitors.
Is Cosmo Bio Co's Total Stockholders Equity too high?
Cosmo Bio Co's current Total Stockholders Equity is 円9,758 Mil. Overall, Cosmo Bio Co has a GF Score™ of 72/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Cosmo Bio Co's Total Stockholders Equity compare to TMO and DHR?
Cosmo Bio Co's Total Stockholders Equity of 円9,758 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Stockholders Equity for a Medical Diagnostics & Research company?
A good Total Stockholders Equity depends on the Medical Diagnostics & Research industry context. However, Total Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Stockholders Equity mean?
A high Total Stockholders Equity can signal that a stock is expensive relative to its fundamentals. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Cosmo Bio Co and its competitors. Cosmo Bio Co's current Total Stockholders Equity is 円9,758 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cosmo Bio Co stock overvalued right now?
Based on GuruFocus' analysis, Cosmo Bio Co (TSE:3386) is currently considered Fairly Valued. The stock's GF Value™ is 円1,314.21, compared to a current price of 円1,246.00 — trading 5.2% below its estimated fair value. The current Total Stockholders Equity is 円9,758 Mil. Cosmo Bio Co's overall GF Score™ is 72/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Stockholders Equity calculated?
Total Stockholders Equity is calculated from a company's financial statements. For Cosmo Bio Co (TSE:3386), the current Total Stockholders Equity is 円9,758 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cosmo Bio Co (TSE:3386) Overvalued in 2026?

Based on GuruFocus' analysis, Cosmo Bio Co stock appears to be undervalued. The current stock price of 円1,246.00 is trading 5.2% below its estimated GF Value™ of 円1,314.21. GuruFocus considers Cosmo Bio Co to be Fairly Valued.

Key valuation signals for TSE:3386:

  • Total Stockholders Equity: 円9,758 Mil
  • GF Value™: 円1,314.21 vs. price of 円1,246.00 (5.2% below fair value)
  • GF Score™: 72/100 with 4 warning signs

No single metric tells the full story. See the TSE:3386 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cosmo Bio Co Business Description

Address 2-20, Toyo-Ekimae Building, Toyo 2-Chome, Koto-ku, Tokyo, JPN, 135-0016
Cosmo Bio Co Ltd is a diagnostic and research company based in Japan. The business of the company includes the purchase of reagents, instruments, and clinical test drugs for research in life science and domestic sales.
72GF Score

Get the complete analysis for TSE:3386

Total Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円1,246.00
Price
円1,314.21
GF Value